Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Katayama

Showing results (71-80 of 149) with videos related to

Pageof 15
Sort By:
World Journal of Urology|May 28, 2021
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic reviewEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
International Journal of Clinical Oncology|November 10, 2021
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
Immunotherapy|April 25, 2022
Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
Urologic Oncology|August 17, 2021
Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysisEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Central European Journal of Urology|January 27, 2022
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysisAbdulmajeed Aydh, Reza Sari Motlagh, Mishari Alshyarba, et al.
European Urology Open Science|October 9, 2025
Rectal Swab-based Targeted Prophylactic Antibiotics Reduce Infectious Complications After Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled TrialsIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
International Journal of Clinical Oncology|March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxelTakuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
BJU International|March 8, 2021
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trialsReza Sari Motlagh, Keiichiro Mori, Ekaterina Laukhtina, et al.
Urologic Oncology|October 5, 2024
Propensity score-matched analysis comparing robot-assisted partial nephrectomy and image-guided percutaneous cryoablation for cT1 renal cell carcinomaTomoaki Yamanoi, Kensuke Bekku, Kasumi Yoshinaga, et al.
Pageof 15

Showing results (71-80 of 149) with videos related to

Sort By:
Pageof 15
World Journal of Urology|May 28, 2021
Oncologic impact of delaying radical prostatectomy in men with intermediate- and high-risk prostate cancer: a systematic reviewEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
International Journal of Clinical Oncology|November 10, 2021
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
Immunotherapy|April 25, 2022
Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysisTakafumi Yanagisawa, Keiichiro Mori, Satoshi Katayama, et al.
Urologic Oncology|August 17, 2021
Adjuvant therapy with tyrosine kinase inhibitors for localized and locally advanced renal cell carcinoma: an updated systematic review and meta-analysisEkaterina Laukhtina, Fahad Quhal, Keiichiro Mori, et al.
Central European Journal of Urology|January 27, 2022
Association of statins use and mortality outcomes in prostate cancer patients who received androgen deprivation therapy: a systematic review and meta-analysisAbdulmajeed Aydh, Reza Sari Motlagh, Mishari Alshyarba, et al.
European Urology Open Science|October 9, 2025
Rectal Swab-based Targeted Prophylactic Antibiotics Reduce Infectious Complications After Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled TrialsIchiro Tsuboi, Mehdi Kardoust Parizi, Akihiro Matsukawa, et al.
International Journal of Clinical Oncology|March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxelTakuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
Chemotherapy is superior to checkpoint inhibitors after radical surgery for urothelial carcinoma: a systematic review and network meta-analysis of oncologic and toxicity outcomesEkaterina Laukhtina, Reza Sari Motlagh, Keiichiro Mori, et al.
BJU International|March 8, 2021
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trialsReza Sari Motlagh, Keiichiro Mori, Ekaterina Laukhtina, et al.
Urologic Oncology|October 5, 2024
Propensity score-matched analysis comparing robot-assisted partial nephrectomy and image-guided percutaneous cryoablation for cT1 renal cell carcinomaTomoaki Yamanoi, Kensuke Bekku, Kasumi Yoshinaga, et al.
Pageof 15